Cost-Effectiveness Analysis of No Adjuvant Therapy Versus Partial Breast Irradiation Alone Versus Combined Treatment for Treatment of Low-Risk DCIS: A Microsimulation.
Matthew C WardFrank ViciniZahraa Al-HilliManjeet ChadhaAbel AbrahamAbram RechtJames HaymanNikhil G ThakerAtif J KhanMartin KeischChriag S ShahPublished in: JCO oncology practice (2021)
No adjuvant therapy represents the most cost-effective approach for postmenopausal women 60 years or older who receive partial mastectomy for low-risk ductal carcinoma in situ.